TFRC and central nervous system cancer: Focusing on delivery strategies for diseases of the central nervous system, targeting of siRNA to glioma cells and neurons has been achieved using tandem peptides decorated with a transferrin-receptor targeting domain in vitro25, and with peptides derived from rabies virus glycoprotein in a mouse model of traumatic brain injury57.